InsideArbitrage Event Driven Monitor – November 21, 2025
Merger Arbitrage
- EXAS: The acquisition of Exact Sciences Corporation (EXAS) by Abbott Laboratories (ABT) for a closing value of $23 billion. Abbott will acquire all outstanding shares of Exact Sciences for $105 per common share in cash, representing a premium of 21.84% from the stock’s last close. (Press Release)
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
